Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy

Completed · Phase 2

Conditions studied: Chronic Patellar Tendinopathy, Chronic PT

In brief

The goal of this study is to find an effective treatment for chronic patellar tendinopathy (PT). Investigators will conduct a 32-week randomized controlled clinical trial to determine whether platelet rich plasma (PRP) injections improve disease-specific clinical outcomes with correlation to a new method of ultrasound (US) imaging assessment called Acoustoelastography (AE). Positive findings of PRP compared to control would suggest future larger scale studies to help establish an optimal protocol for the nonsurgical management of PT.

Key facts

Study ID
NCT01843504
Run by
University of Wisconsin, Madison
People needed
29
Starts
2014-02-25
Expected to finish
2024-02-29
Last updated by the study team
2026-07-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.